Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2021

Upgrades

Macquarie upgraded the previous rating for ZTO Express (Cayman) Inc ZTO from Neutral to Outperform. ZTO Express (Cayman) earned $0.22 in the third quarter, compared to $0.23 in the year-ago quarter. At the moment, the stock has a 52-week-high of $38.96 and a 52-week-low of $25.23. ZTO Express (Cayman) closed at $28.82 at the end of the last trading period.

According to B of A Securities, the prior rating for ZTO Express (Cayman) Inc ZTO was changed from Neutral to Buy. In the third quarter, ZTO Express (Cayman) showed an EPS of $0.22, compared to $0.23 from the year-ago quarter. The current stock performance of ZTO Express (Cayman) shows a 52-week-high of $38.96 and a 52-week-low of $25.23. Moreover, at the end of the last trading period, the closing price was at $28.82.

For The Hain Celestial Group Inc HAIN, Evercore ISI Group upgraded the previous rating of In-Line to Outperform. In the first quarter, Hain Celestial Group showed an EPS of $0.25, compared to $0.27 from the year-ago quarter. The stock has a 52-week-high of $48.88 and a 52-week-low of $35.57. At the end of the last trading period, Hain Celestial Group closed at $40.78.

According to JP Morgan, the prior rating for GoPro Inc GPRO was changed from Neutral to Overweight. In the third quarter, GoPro showed an EPS of $0.34, compared to $0.20 from the year-ago quarter. At the moment, the stock has a 52-week-high of $13.79 and a 52-week-low of $6.38. GoPro closed at $11.55 at the end of the last trading period.

For Oatly Group AB OTLY, Morgan Stanley upgraded the previous rating of Equal-Weight to Overweight. The stock has a 52-week-high of $29.00 and a 52-week-low of $9.05. At the end of the last trading period, Oatly Group closed at $9.44.

Jefferies upgraded the previous rating for Hilton Grand Vacations Inc HGV from Hold to Buy. For the third quarter, Hilton Grand Vacations had an EPS of $0.90, compared to year-ago quarter EPS of $0.08. The stock has a 52-week-high of $56.33 and a 52-week-low of $26.57. At the end of the last trading period, Hilton Grand Vacations closed at $51.96.

For Evolent Health Inc EVH, JP Morgan upgraded the previous rating of Neutral to Overweight. Evolent Health earned $0.03 in the third quarter, compared to $0.03 in the year-ago quarter. The current stock performance of Evolent Health shows a 52-week-high of $34.60 and a 52-week-low of $13.15. Moreover, at the end of the last trading period, the closing price was at $27.79.

For IHS Holding Ltd IHS, JP Morgan upgraded the previous rating of Neutral to Overweight. In the second quarter, IHS Holding showed an EPS of $1.60, compared to $1.50 from the year-ago quarter.

JP Morgan upgraded the previous rating for Endeavor Group Holdings Inc EDR from Neutral to Overweight. The current stock performance of Endeavor Group Holdings shows a 52-week-high of $33.20 and a 52-week-low of $22.02. Moreover, at the end of the last trading period, the closing price was at $29.51.

According to JP Morgan, the prior rating for Boeing Co BA was changed from Neutral to Overweight. Boeing earned $0.60 in the third quarter, compared to $1.39 in the year-ago quarter. The stock has a 52-week-high of $278.57 and a 52-week-low of $191.85. At the end of the last trading period, Boeing closed at $226.62.

According to Stifel, the prior rating for DCP Midstream LP DCP was changed from Hold to Buy. In the third quarter, DCP Midstream showed an EPS of $0.18, compared to $0.46 from the year-ago quarter. The current stock performance of DCP Midstream shows a 52-week-high of $33.84 and a 52-week-low of $15.01. Moreover, at the end of the last trading period, the closing price was at $29.88.

See all analyst ratings upgrades.

Downgrades

Evercore ISI Group downgraded the previous rating for Lexington Realty Trust LXP from Outperform to In-Line. For the third quarter, Lexington Realty had an EPS of $0.19, compared to year-ago quarter EPS of $0.19. The current stock performance of Lexington Realty shows a 52-week-high of $15.37 and a 52-week-low of $9.98. Moreover, at the end of the last trading period, the closing price was at $15.34.

According to SVB Leerink, the prior rating for Atea Pharmaceuticals Inc AVIR was changed from Outperform to Market Perform. For the third quarter, Atea Pharmaceuticals had an EPS of $0.34, compared to year-ago quarter EPS of $1.74. The current stock performance of Atea Pharmaceuticals shows a 52-week-high of $94.17 and a 52-week-low of $8.53. Moreover, at the end of the last trading period, the closing price was at $8.69.

B of A Securities downgraded the previous rating for Banco Santander Mexico SA BSMX from Buy to Underperform. For the third quarter, Banco Santander Mexico had an EPS of $0.04, compared to year-ago quarter EPS of $0.03. At the moment, the stock has a 52-week-high of $6.67 and a 52-week-low of $4.49. Banco Santander Mexico closed at $6.35 at the end of the last trading period.

According to JP Morgan, the prior rating for Activision Blizzard Inc ATVI was changed from Overweight to Neutral. For the third quarter, Activision Blizzard had an EPS of $0.72, compared to year-ago quarter EPS of $0.71. The stock has a 52-week-high of $104.53 and a 52-week-low of $63.50. At the end of the last trading period, Activision Blizzard closed at $64.20.

See all analyst ratings downgrades.

Initiations

Morgan Stanley initiated coverage on Phibro Animal Health Corp PAHC with a Equal-Weight rating. The price target for Phibro Animal Health is set to ('$23.00', False). For the first quarter, Phibro Animal Health had an EPS of $0.25, compared to year-ago quarter EPS of $0.27. The current stock performance of Phibro Animal Health shows a 52-week-high of $31.00 and a 52-week-low of $17.70. Moreover, at the end of the last trading period, the closing price was at $21.68.

Morgan Stanley initiated coverage on Elanco Animal Health Inc ELAN with an Overweight rating. The price target for Elanco Animal Health is set to ('$40.00', False). Elanco Animal Health earned $0.19 in the third quarter, compared to $0.13 in the year-ago quarter. The stock has a 52-week-high of $37.49 and a 52-week-low of $27.33. At the end of the last trading period, Elanco Animal Health closed at $31.95.

With an Overweight rating, Morgan Stanley initiated coverage on Zoetis Inc ZTS. The price target seems to have been set at ('$264.00', False) for Zoetis. For the third quarter, Zoetis had an EPS of $1.25, compared to year-ago quarter EPS of $1.10. At the moment, the stock has a 52-week-high of $222.60 and a 52-week-low of $141.41. Zoetis closed at $221.87 at the end of the last trading period.

Morgan Stanley initiated coverage on PetMed Express Inc PETS with an Underweight rating. The price target for PetMed Express is set to ('$25.00', False). In the second quarter, PetMed Express showed an EPS of $0.31, compared to $0.42 from the year-ago quarter. The current stock performance of PetMed Express shows a 52-week-high of $57.00 and a 52-week-low of $24.75. Moreover, at the end of the last trading period, the closing price was at $30.12.

With an Overweight rating, Morgan Stanley initiated coverage on IDEXX Laboratories Inc IDXX. The price target seems to have been set at ('$732.00', False) for IDEXX Laboratories. For the third quarter, IDEXX Laboratories had an EPS of $2.03, compared to year-ago quarter EPS of $1.69. At the moment, the stock has a 52-week-high of $706.95 and a 52-week-low of $443.14. IDEXX Laboratories closed at $627.99 at the end of the last trading period.

Morgan Stanley initiated coverage on Heska Corp HSKA with a Equal-Weight rating. The price target for Heska is set to ('$190.00', False). Heska earned $0.20 in the third quarter, compared to $0.08 in the year-ago quarter. At the moment, the stock has a 52-week-high of $275.94 and a 52-week-low of $121.50. Heska closed at $180.98 at the end of the last trading period.

With a Equal-Weight rating, Morgan Stanley initiated coverage on Covetrus Inc CVET. The price target seems to have been set at ('$19.00', False) for Covetrus. Covetrus earned $0.23 in the third quarter, compared to $0.33 in the year-ago quarter. The current stock performance of Covetrus shows a 52-week-high of $40.77 and a 52-week-low of $16.99. Moreover, at the end of the last trading period, the closing price was at $18.60.

Imperial Capital initiated coverage on Latch Inc LTCH with an Outperform rating. The price target for Latch is set to ('$15.00', False). At the moment, the stock has a 52-week-high of $14.83 and a 52-week-low of $8.10. Latch closed at $8.83 at the end of the last trading period.

DA Davidson initiated coverage on Okta Inc OKTA with a Buy rating. The price target for Okta is set to ('$315.00', False). In the second quarter, Okta showed an EPS of $0.11, compared to $0.07 from the year-ago quarter. The current stock performance of Okta shows a 52-week-high of $294.00 and a 52-week-low of $199.08. Moreover, at the end of the last trading period, the closing price was at $266.42.

With a Sell rating, Arete Research initiated coverage on AppLovin Corp APP. The price target seems to have been set at ('$82.00', False) for AppLovin. At the moment, the stock has a 52-week-high of $116.09 and a 52-week-low of $49.41. AppLovin closed at $105.42 at the end of the last trading period.

BTIG initiated coverage on Enjoy Technology Inc ENJY with a Buy rating. The price target for Enjoy Technology is set to ('$10.00', False).

With an Underweight rating, Barclays initiated coverage on Cronos Group Inc CRON. The price target seems to have been set at ('$5.50', False) for Cronos Group. In the second quarter, Cronos Group showed an EPS of $0.15, compared to $0.19 from the year-ago quarter. The stock has a 52-week-high of $15.83 and a 52-week-low of $5.11. At the end of the last trading period, Cronos Group closed at $5.55.

Barclays initiated coverage on Canopy Growth Corp CGC with a Equal-Weight rating. The price target for Canopy Gwth is set to ('$14.00', False). Canopy Gwth earned $0.02 in the second quarter, compared to $0.22 in the year-ago quarter. The stock has a 52-week-high of $56.50 and a 52-week-low of $11.31. At the end of the last trading period, Canopy Gwth closed at $13.60.

JP Morgan initiated coverage on FREYR Battery FREY with a Neutral rating. The price target for FREYR Battery is set to ('$14.70', False). In the third quarter, FREYR Battery showed an EPS of $0.42, compared to $0.07 from the year-ago quarter. The current stock performance of FREYR Battery shows a 52-week-high of $14.37 and a 52-week-low of $7.71. Moreover, at the end of the last trading period, the closing price was at $13.72.

With an Outperform rating, Raymond James initiated coverage on Cyxtera Technologies Inc CYXT. The price target seems to have been set at ('$12.00', False) for Cyxtera Technologies.

Raymond James initiated coverage on Vivid Seats Inc SEAT with an Outperform rating. The price target for Vivid Seats is set to ('$17.00', False).

SVB Leerink initiated coverage on Viridian Therapeutics Inc VRDN with an Outperform rating. The price target for Viridian Therapeutics is set to ('$32.00', False). In the third quarter, Viridian Therapeutics showed an EPS of $1.25, compared to $1.48 from the year-ago quarter. The stock has a 52-week-high of $25.19 and a 52-week-low of $10.44. At the end of the last trading period, Viridian Therapeutics closed at $19.00.

With an Outperform rating, William Blair initiated coverage on Confluent Inc CFLT. The price target seems to have been set at ('No Price Target', True) for Confluent. The current stock performance of Confluent shows a 52-week-high of $94.97 and a 52-week-low of $37.71. Moreover, at the end of the last trading period, the closing price was at $79.82.

Barclays initiated coverage on The Scotts Miracle Gro Co SMG with an Overweight rating. The price target for Scotts Miracle Gro is set to ('$205.00', False). Scotts Miracle Gro earned $0.82 in the fourth quarter, compared to $0.06 in the year-ago quarter. The stock has a 52-week-high of $254.34 and a 52-week-low of $139.20. At the end of the last trading period, Scotts Miracle Gro closed at $168.75.

With an Underweight rating, Barclays initiated coverage on Tilray Inc TLRY. The price target seems to have been set at ('$10.00', False) for Tilray. For the first quarter, Tilray had an EPS of $0.08, compared to year-ago quarter EPS of $1.75. The stock has a 52-week-high of $67.00 and a 52-week-low of $6.66. At the end of the last trading period, Tilray closed at $12.34.

With a Buy rating, Mizuho initiated coverage on Cheniere Energy Inc LNG. The price target seems to have been set at ('$122.00', False) for Cheniere Energy. Cheniere Energy earned $4.27 in the third quarter, compared to $1.84 in the year-ago quarter. At the moment, the stock has a 52-week-high of $113.40 and a 52-week-low of $52.25. Cheniere Energy closed at $104.89 at the end of the last trading period.

Mizuho initiated coverage on Relmada Therapeutics Inc RLMD with a Buy rating. The price target for Relmada Therapeutics is set to ('$50.00', False). For the third quarter, Relmada Therapeutics had an EPS of $2.44, compared to year-ago quarter EPS of $1.05. The stock has a 52-week-high of $40.00 and a 52-week-low of $20.60. At the end of the last trading period, Relmada Therapeutics closed at $21.45.

With a Buy rating, UBS initiated coverage on Square Inc SQ. The price target seems to have been set at ('$322.00', False) for Square. Square earned $0.37 in the third quarter, compared to $0.34 in the year-ago quarter. At the moment, the stock has a 52-week-high of $289.23 and a 52-week-low of $180.12. Square closed at $231.85 at the end of the last trading period.

UBS initiated coverage on Fiserv Inc FISV with a Neutral rating. The price target for Fiserv is set to ('$108.00', False). In the third quarter, Fiserv showed an EPS of $1.47, compared to $1.20 from the year-ago quarter. The stock has a 52-week-high of $127.34 and a 52-week-low of $94.39. At the end of the last trading period, Fiserv closed at $100.88.

UBS initiated coverage on Global Payments Inc GPN with a Buy rating. The price target for Global Payments is set to ('$161.00', False). For the third quarter, Global Payments had an EPS of $2.18, compared to year-ago quarter EPS of $1.71. The current stock performance of Global Payments shows a 52-week-high of $220.81 and a 52-week-low of $122.56. Moreover, at the end of the last trading period, the closing price was at $125.51.

With a Neutral rating, UBS initiated coverage on Jack Henry & Associates Inc JKHY. The price target seems to have been set at ('$162.00', False) for Jack Henry & Associates. In the first quarter, Jack Henry & Associates showed an EPS of $1.38, compared to $1.19 from the year-ago quarter. The current stock performance of Jack Henry & Associates shows a 52-week-high of $179.98 and a 52-week-low of $141.65. Moreover, at the end of the last trading period, the closing price was at $153.80.

See all analyst ratings initiations.